Natrecor

Indicated For

acute decompensated heart failure

About This Medication

# Natrecor (Nesiritide) Patient Guide: How to Get Natrecor at Low or No Cost **Important Notice: Natrecor (nesiritide) is currently discontinued by its manufacturer, Janssen, with no available presentations on the market.** This means there is no active prescription assistance program providing the drug at low or no cost, as supply has ended. Patients should consult their doctor for alternative treatments for acutely decompensated heart failure (ADHF).[7] Despite the lack of a specific program, this guide explains what a typical patient assistance program (PAP) might involve, based on standard practices for similar medications, and provides general steps for seeking help with heart failure treatments. ## About Natrecor (Nesiritide) Natrecor, or **nesiritide**, is an intravenous medication FDA-approved on August 10, 2001, for treating patients with **acutely decompensated congestive heart failure (ADHF)** who experience **dyspnea (shortness of breath) at rest or with minimal activity**. It works by relaxing and dilating blood vessels, which lowers blood pressure, reduces pulmonary capillary wedge pressure, and improves breathing.[1][2][3][8] It's given as an IV bolus of 2 mcg/kg followed by a continuous infusion of 0.01 mcg/kg/min, typically for up to 48 hours in a hospital setting. It's not for chronic heart failure, cardiogenic shock, or low blood pressure (systolic <90 mm Hg).[1][2][6][8] Common side effects include low blood pressure, headache, nausea, and injection site reactions. Always discuss risks with your doctor, especially if you have allergies or other heart issues.[6][8] **Key Fact:** Due to discontinuation, new prescriptions are not possible. Historical use showed it was often combined with diuretics like furosemide.[8] ## Who Qualifies for Prescription Assistance? Since no specific PAP exists for Natrecor, qualification follows general PAP guidelines from manufacturers or nonprofits. Typically, you qualify if: - You have a valid prescription for an FDA-approved use (here, ADHF with dyspnea).[1][8] - Your income is at or below **400% of the Federal Poverty Level (FPL)** (common threshold; exact % varies). - You are uninsured, underinsured, or face high copays. - You are a U.S. resident (often 18+). Medicare covers Natrecor for ADHF but not chronic HF.[1] Private insurers like Aetna may cover it for acute management.[2] ## Income Eligibility Breakdown Typical PAPs use FPL-based thresholds (2026 guidelines; check HHS.gov for updates). Here's a sample table for a hypothetical Natrecor PAP at 400% FPL: | Household Size | Annual Income Limit (400% FPL) | |----------------|-------------------------------| | 1 (Individual) | $60,320 | | 2 (Couple) | $81,760 | | 3 | $103,200 | | 4 | $124,640 | *Add ~$21,440 per additional person. Notes: Proof of income required (tax returns, pay stubs). Some programs adjust for high medical costs.* ## Insurance Requirements Most PAPs require: - No or inadequate insurance coverage. - Medicare Part D enrollment (but PAPs help with gaps). - Not dual-eligible for Medicaid. For Natrecor, Medicare covers acute use; check your plan.[1] Aetna-like policies deem it necessary for ADHF.[2] Submit insurance denial or Explanation of Benefits (EOB) if applicable. ## Step-by-Step Application Process 1. **Get a Prescription:** Ask your cardiologist for a Natrecor script and PAP referral. Note discontinuation.[7] 2. **Check Eligibility:** Use general PAP search tools like NeedyMeds.org or PAN Foundation. 3. **Gather Documents:** Prescription, photo ID, income proof, insurance card/EOB. 4. **Apply:** Call 1-800 numbers (e.g., Janssen Cares if active) or apply online. For alternatives, contact heart failure foundations. 5. **Submit & Follow Up:** Mail/fax docs; track status. 6. **Receive Approval:** Medication ships to doctor/pharmacy (if available). ## Timeline and Delivery Processing: 2-4 weeks typically. Delivery: Free to prescriber's office or home via specialty pharmacy. Hospital-administered for IV use.[2][8] Refills: Annual reapplication. ## Alternatives if Denied or Unavailable - **Switch Drugs:** Standard HF treatments like IV diuretics (furosemide), dobutamine, or milrinone. Newer options: SGLT2 inhibitors, vericiguat.[1] - **Other PAPs:** PAN Foundation, HealthWell Foundation for heart failure meds. - **Hospital Financial Aid:** Charity care programs. - **Clinical Trials:** Search ClinicalTrials.gov for HF studies (e.g., past nesiritide trials).[5] - **Generic/Compounded:** None available due to discontinuation.[7] ## Disclaimer This guide is for informational purposes only and not medical/financial advice. Natrecor is discontinued as of recent reports—no PAP provides it.[7] Consult your healthcare provider for personalized options. Eligibility/rules change; verify with sources. Not affiliated with Janssen or any PAP. Word count: 912.

Program information last verified: March 30, 2026